Hot Take Nov 20, 2026 · 2 min read

Citi shares touched $110.175 in the regular session, 4.43% below the previous close, and finished at $110.72, down 3.96%.

Citi shares touched $110.175 in the regular session, 4.43% below the previous close, and finished at $110.72, down 3.96%. They traded at $110.99 after hours, up 0.24% from that close. Reuters reported that incorrectly recorded trades at Citi's UK trading subsidiary led to an understatement of about $35 billion in risk-weighted assets.

That's roughly 2.9% of the $1.2 trillion in total RWA Citi reported in its June and September filings. The size of the error got my attention.

Reuters reported that Citi measured those trades with an internal model regulators hadn't approved for those transactions. Using a standard risk model raised their RWA value significantly. I keep coming back to how much the choice of model changed the reported number.

Citi says it found and resolved the issue this summer and injected capital to restore the subsidiary's buffers. It says the subsidiary remained fully compliant with regulatory minimums throughout, with no impact on the holding company or main operating bank. I think those details matter.

Still, I understand why Wells Fargo analyst Mike Mayo said the perception "is not great" after Citi's prior mistakes. Reuters says Citi is targeting paperwork in 2026 to seek removal of regulatory restrictions. My read: this gives regulators another reason to ask hard questions before granting that relief. Whether it changes their decision is unknown.

Sources:
Reuters (via Fidelity): https://www.fidelity.com/news/article/default/202611191838RTRSNEWSCOMBINED_KCN3WU3BY-OUSBS_1
Reuters (via Euronext): https://live.euronext.com/en/financial-news/exclusive-citi-underestimated-risky-assets-35-billion-after-incorrectly-recording

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →